Clinical Trial Update: Adjuvant Therapies for Patients With HCC and MVI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on adjuvant therapies for hepatocellular carcinoma with microvascular invasion (HCC with MVI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN